Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06585501
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-03
Brief Title:
A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric Gastroesophageal Junction Cancer in China
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Treatment and Testing Patterns in HER2-positive Unresectable and Advanced Gastric Gastroesophageal Junction Cancer in China A Retrospective Real-world Study REHEARSAL
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REHEARSAL
Brief Summary:
This study will be conducted to retrospectively evaluate the treatment patterns in first-line second-line and subsequent lines of therapy for HER2-positive Gastric CancerGastroesophageal Junction Cancer GCGEJC patients
Detailed Description:
This is a multicenter non-interventional retrospective real-world study to analyze the treatment patterns for patients with GCGEJC in the first-line second-line and subsequent lines of treatment The study will also assess different HER2 sample types testing methods and HER2 re-biopsy situations By evaluating the treatment and testing patterns in clinical practice this study aims to provide evidence and recommendations for improving the strategies for the treatment and testing of HER2-positive GCGEJC patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None